Clinical Trial Update: Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity

View source ↗

Summary

A clinical trial is evaluating a novel three-dimensional organoid model of hematologic malignancies to study disease biology and responsiveness to chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Hematologic Malignancy | Status: RECRUITING